TITLE

Treatment of tuberculosis

AUTHOR(S)
Cooke, Nigel J.
PUB. DATE
August 1985
SOURCE
British Medical Journal (Clinical Research Edition);8/24/1985, Vol. 291 Issue 6495, p497
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on the treatment of tuberculosis in Great Britain. Discovery of rifampicin and ethambutol; Re-appraisal of pyrazinamide; Discussion on the difficulty of changing doctors' prescribing habits in tuberculosis.
ACCESSION #
4920643

 

Related Articles

  • Coma and brain stem areflexia in brain stem encephalitis (Fisher's syndrome). Al-Din, A S; Jamil, A S; Shakir, R // British Medical Journal (Clinical Research Edition);Aug1985, Vol. 291 Issue 6494, p535 

    No abstract available.

  • Effectiveness of 3 months of rifampicin and isoniazid chemoprophylaxis for the treatment of latent tuberculosis infection in children. Bright-Thomas, R.; Nandwani, S.; Smith, J.; Morris, J. A.; Ormerod, L. P. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Aug2010, Vol. 95 Issue 8, p5 

    Background/setting Treatment for 3 months with rifampicin (R) and isoniazid (H) (3RH) for latent tuberculosis infection (LTBI), defined as an inappropriately positive tuberculin skin test with no clinical or x-ray evidence of disease, has been used locally since 1989. The efficacy of this...

  • Better tolerability makes rifampicin cheaper option for latent TB.  // PharmacoEconomics & Outcomes News;8/21/2010, Issue 610, p9 

    The article focuses on the study comparing the costs of rifampicin therapy and the currently recommended standard regiment of nine months of isoniazid for treating latent tuberculosis (TB) by Anne Aspler and colleagues, published in an issue of "Thorax."

  • Short-Course Chemotherapy for Extrapulmonary Tuberculosis. Dutt, Asim K.; Moers, Dory; Stead, William W. // Annals of Internal Medicine;Jan86, Vol. 104 Issue 1, p7 

    Presents information on a study which described the use of short-course chemotherapy with isoniazid and rifampicin for extrapulmonary tuberculosis. Methods; Results; Discussion.

  • Suppression of T--Lymphocyte Rosettes by Rifampin. Gupta, Sudhir; Siegel, Israel; Grieco, Michael H. // Annals of Internal Medicine;Apr75, Vol. 82 Issue 4, p484 

    Examines the effects of therapeutic doses of rifampin on circulating T and B lymphocytes in patients receiving chemotherapy for tuberculosis. Impact of rifampin on T-lymphocytes rosettes circulation and total lymphocyte counts; Suppression of peripheral blood B lymphocytes during rifampin...

  • Rifampicin preferred option for LTBI control.  // PharmacoEconomics & Outcomes News;1/26/2013, Issue 670, p9 

    The article discusses research which revealed that rifampicin is more cost effective that isoniazid in managing latent tuberculosis infection (LTBI) in Spain, referencing a study by J. M. Pina and colleagues, published in the "European Journal of Clinical Microbiology and Infectious Diseases."

  • Rifampicin.  // Reactions Weekly;10/10/2009, Issue 1273, p29 

    The article describes the case of a 25-year-old man who developed severe headache while receiving rifampicin for tuberculosis. The patient reportedly experienced head ache 3 to 4 hours after ingestion of anti-TB regimen that include rifampicin, isoniazid, pyrazinamide and ethambutol. Adverse...

  • Rifampicin.  // Reactions Weekly;10/27/2007, Issue 1175, p21 

    The article describes the case of a 34-year-old woman who developed hypothyroidism during treatment with rifampicin for miliary tuberculosis. The patient was hospitalised and started receiving rifampicin 0.45g, isoniazid, ethambutol and pyrazinamide. Two weeks after antitubercular initiation,...

  • Relationship between CES2 genetic variations and rifampicin metabolism. Song, Sang Hoon; Chang, Ho Eun; Jun, Sun Hee; Park, Kyoung Un; Lee, Jae Ho; Lee, Eun-Mi; Song, Young-Han; Song, Junghan // Journal of Antimicrobial Chemotherapy (JAC);Jun2013, Vol. 68 Issue 6, p1281 

    Objectives Rifampicin is known to be deacetylated in vivo, resulting in its metabolite 25-desacetyl rifampicin, but the enzyme metabolizing rifampicin and the association of this process with any genetic variation have not yet been elucidated. In this study, genetic variations of a surrogate...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics